Pixels & Pills

Entries Tagged as 'transparency'

Defining Moments: WikiLeaks

July 6th, 2011 · No Comments · Uncategorized

The Defining Moments series looks back at the biggest events of 2010 to see what we can learn from them here at P&P, to work better in our calling, in 2011 and beyond.

In July 2010, over 90 thousand documents related to the war in Afghanistan were leaked by WikiLeaks to major [...]

Share

[Read more →]

Tags:········

Could Pharma Learn How to be More Open and Cutting-Edge from the FDA?

June 6th, 2011 · 2 Comments · Uncategorized

By Rob Kempton (@manonthemooncon)
When you think cutting-edge use of social media, you’re probably not thinking of the FDA. While the agency has been criticized for not expediently issuing social media guidelines for pharma, they’re getting up to speed using social media to promote transparency in the agency’s operations, activities, processes and decision-making. The FDA released [...]

Share

[Read more →]

Tags:··················

Generation Y and Health: The Healthcare Revolution

April 19th, 2011 · No Comments · Knowledge, Opinion

This post continues our new series on Generation Y and their relationship with their health. From challenges to epidemics, this series attempts to expose how these digital natives are managing health-related issues, both individually and together.
By Kimberly Reyes (@CommDuCoeur)
In my last installment in this series on the Millennial doctor, [...]

Share

[Read more →]

Tags:··························

Why your Crisis Communication Plan Needs a Makeover

March 24th, 2011 · No Comments · Uncategorized

By Carl Turner (@leftyrightbrain)
When was the last time you updated your crisis communication plan? Social media has been great for creating conversations between companies and customers, but it’s also providing new opportunities for generating gaffes. Most recently, a new media agency employee dropped an F-bomb on Chrysler’s corporate Twitter account.
Pharma is no stranger to crisis [...]

Share

[Read more →]

Tags:················

Tips for Making Your Content King

March 1st, 2011 · No Comments · Knowledge

By Todd LaRoche (@ToddLaRoche)
Interactions take place online more so now than ever before. Even if you’re not expanding your Web site strategy or participating in social media, chances are your competitors are; they’re blogging, sending electronic newsletters, tweeting, and posting to their Facebook account and LinkedIn groups. With everyone vying for the attention of potential [...]

Share

[Read more →]

Tags:·················

The Application of Offline Skills for Social Media Success

August 26th, 2010 · No Comments · Opinion

By Todd LaRoche (@toddlaroche)
Whether you’re just dabbling in social media or if blogging, posting, friending and following are already old hat, your people skills can make or break your social media success. In the boardroom or on discussion boards and social media sites, proper business etiquette can be a key differentiator that delivers a competitive [...]

Share

[Read more →]

Tags:···········

Pharma’s Bill of Rights

May 10th, 2010 · 5 Comments · Opinion

This post is the first in a week-long series that asks “What would the government regulate?”  We’ll be talking about government concerns, healthcare scares, the impact of reform, and more.
By Sven Larsen (@zemoga)
The FDA needs to let the pharmaceutical industry provide information online. Yes, there’s been plenty of disagreement over exactly how this ought to [...]

Share

[Read more →]

Tags:········

NEWS BYTE: CMSS’ “Code for Interactions with Companies”

April 29th, 2010 · 2 Comments · News, Opinion

This news story is part of our week-long discussion around the theme of communication: how to speak to specific healthcare communities, and best practices for pharma executives.
By Leah Warner
The commercial interests of pharmaceutical companies continue to remain under scrutiny as evidenced by the recent announcement of the Council of Medical Specialty Societies (CMSS) “Code for [...]

Share

[Read more →]

Tags:···········